Jump Financial, LLC Amarin Corp Plcuk Transaction History

Jump Financial, LLC

$4.56 Billion
Q3 2024

A detailed history of Jump Financial, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Jump Financial, LLC holds 10,909 shares of AMRN stock, worth $5,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,909

Holding current value

$5,672

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.57 - $0.8 $6,218 - $8,727	10,909 New	10,909 $6,000
Q2 2022 Aug 09, 2022	SELL	$1.13 - $3.69 $35,030 - $114,390	-31,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.85 - $3.73 $706,515 - $924,667	-247,900 Reduced 88.88%	31,000 $102,000
Q4 2021 Feb 10, 2022	SELL	$3.24 - $5.18 $446,565 - $713,954	-137,829 Reduced 33.07%	278,900 $940,000
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $295,669 - $438,251	75,043 Added 21.96%	416,729 $2.13 Million
Q2 2021 Aug 13, 2021	BUY	$4.26 - $6.5 $873,704 - $1.33 Million	205,095 Added 150.15%	341,686 $1.5 Million
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $105,916 - $185,301	-21,057 Reduced 13.36%	136,591 $848,000
Q4 2020 Feb 12, 2021	BUY	$4.04 - $5.31 $91,093 - $119,729	22,548 Added 16.69%	157,648 $771,000
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $491,764 - $1.05 Million	135,100 New	135,100 $569,000

Others Institutions Holding AMRN

# of Institutions

178

Shares Held

65.3M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$12.9 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$6.46 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.72 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.32 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.3 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account